FDA has new leverage over companies looking for a quicker drug approval

Congress gave the Food and Drug Administration more power to hold drugmakers accountable as part of the mammoth spending bill that became law in December 2022.

The Food and Drug Administration has new tools to hold drug companies accountable for promises they make about medications. But the agency has yet to show its hand in using this new power.

(Image credit: Sarah Silbiger/Getty Images)

Read the full post on Health Care : NPR

Sydney Lupkin